Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride effectively treat hair loss.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Stem cells from hair follicles can safely treat hair loss.

Finasteride increases hair weight and count in men with hair loss.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Hidradenitis suppurativa improves with antiandrogen therapy.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Scutellaria baicalensis extract and baicalin may help prevent hair loss.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Mutations in certain receptors can cause diseases and offer new treatment options.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.